Intravital microscopy and laser Doppler fluxmetry (LDF) were used to assess vasomotion and flux motion in skeletal muscle microcirculation. To clarify the relation between vessel type and LDF signals, arterioles, capillaries, and venules were sequentially studied. We used as an experimental model the hamster skin fold window preparation to record vasomotion and flux motion under control conditions and after injection of an α2-adrenoceptor antagonist, yohimbine, since terminal arterioles appear to be subserved primarily by α2-adrenoceptors. LDF signals were characterized by using an autoregressive modeling power spectrum technique. This analysis indicated that the flux motion fundamental frequency of terminal arterioles coincided with order 2 arteriole vasomotion fundamental frequency. The LDF fundamental frequency of order 3 arterioles was synchronous with the vasomotion frequency in the same-order vessels. The LDF fundamental frequency of order 3 venules corresponded to the frequency component coincident with the respiratory rate. The pattern of LDF oscillations was peculiar for each type of vessels, and the total power was greater in larger arterioles than in venules. Yohimbine reduced frequency and amplitude of vasomotion and flux motion in terminal arterioles, but it was possible to detect LDF oscillatory patterns due to the activity of parent vessels with a low frequency. In conclusion, the flux motion is fundamentally dependent on the type of vessel from which it originates and is directly related to the vasomotion of the arterioles.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.